Advertisement

Topics

M&A this week: Oxis International, Hangzhou Tianmushan, Zhejiang Jingxin Pharmaceutical

19:00 EDT 29 Jun 2017 | Pharmaceutical Technology

Immuno-oncology drug developer Oxis International has agreed to buy Georgetown Translational Pharmaceuticals (GTP) in exchange of 33% of its outstanding shares.

Original Article: M&A this week: Oxis International, Hangzhou Tianmushan, Zhejiang Jingxin Pharmaceutical

NEXT ARTICLE

More From BioPortfolio on "M&A this week: Oxis International, Hangzhou Tianmushan, Zhejiang Jingxin Pharmaceutical"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...